Search

Valarie E. Bertoglio

Examiner (ID: 15710, Phone: (571)272-0725 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
1314
Issued Applications
630
Pending Applications
181
Abandoned Applications
515

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17505496 [patent_doc_number] => 20220098598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => METHODS FOR MODIFYING THE GROWTH RATE OF A CELL [patent_app_type] => utility [patent_app_number] => 17/552720 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552720 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/552720
METHODS FOR MODIFYING THE GROWTH RATE OF A CELL Dec 15, 2021 Pending
Array ( [id] => 18970432 [patent_doc_number] => 20240050524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => DELIVERY OF ABETA VARIANTS FOR AGGREGATION INHIBITION [patent_app_type] => utility [patent_app_number] => 18/267980 [patent_app_country] => US [patent_app_date] => 2021-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48299 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267980 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/267980
DELIVERY OF ABETA VARIANTS FOR AGGREGATION INHIBITION Dec 14, 2021 Pending
Array ( [id] => 17519304 [patent_doc_number] => 20220105152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => Composition for and Method of Treating Hepatic Tissue Injury [patent_app_type] => utility [patent_app_number] => 17/549105 [patent_app_country] => US [patent_app_date] => 2021-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10546 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17549105 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/549105
Composition for and Method of Treating Hepatic Tissue Injury Dec 12, 2021 Abandoned
Array ( [id] => 17480633 [patent_doc_number] => 20220088137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES [patent_app_type] => utility [patent_app_number] => 17/542997 [patent_app_country] => US [patent_app_date] => 2021-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37592 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542997 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/542997
METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES Dec 5, 2021 Abandoned
Array ( [id] => 17625818 [patent_doc_number] => 20220160833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES [patent_app_type] => utility [patent_app_number] => 17/542992 [patent_app_country] => US [patent_app_date] => 2021-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37593 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17542992 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/542992
METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES Dec 5, 2021 Pending
Array ( [id] => 17480634 [patent_doc_number] => 20220088138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES [patent_app_type] => utility [patent_app_number] => 17/543020 [patent_app_country] => US [patent_app_date] => 2021-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37591 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17543020 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/543020
METHODS FOR DETECTING AND MODULATING THE EMBRYONIC-FETAL TRANSITION IN MAMMALIAN SPECIES Dec 5, 2021 Abandoned
Array ( [id] => 17460570 [patent_doc_number] => 20220073875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => Amplifiable RNAs for Therapeutic Cell Systems [patent_app_type] => utility [patent_app_number] => 17/529686 [patent_app_country] => US [patent_app_date] => 2021-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35656 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -70 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529686 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/529686
Amplifiable RNAs for Therapeutic Cell Systems Nov 17, 2021 Abandoned
Array ( [id] => 17457880 [patent_doc_number] => 20220071184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => RED TRANSGENIC FLUORESCENT ORNAMENTAL FISH [patent_app_type] => utility [patent_app_number] => 17/528936 [patent_app_country] => US [patent_app_date] => 2021-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528936 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/528936
Red transgenic fluorescent ornamental fish Nov 16, 2021 Issued
Array ( [id] => 17911325 [patent_doc_number] => 20220313720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => TARGETED CANCER THERAPY [patent_app_type] => utility [patent_app_number] => 17/528827 [patent_app_country] => US [patent_app_date] => 2021-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12379 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528827 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/528827
TARGETED CANCER THERAPY Nov 16, 2021 Abandoned
Array ( [id] => 17400005 [patent_doc_number] => 20220042095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => METHODS AND COMPOSITIONS FOR MONITORING AND ENHANCING EARLY EMBRYO DEVELOPMENT [patent_app_type] => utility [patent_app_number] => 17/511092 [patent_app_country] => US [patent_app_date] => 2021-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11050 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511092 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/511092
METHODS AND COMPOSITIONS FOR MONITORING AND ENHANCING EARLY EMBRYO DEVELOPMENT Oct 25, 2021 Abandoned
Array ( [id] => 17385995 [patent_doc_number] => 20220033847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => NON-HUMAN ANIMALS EXPRESSING HUMANIZED C1Q COMPLEX [patent_app_type] => utility [patent_app_number] => 17/506730 [patent_app_country] => US [patent_app_date] => 2021-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31952 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -86 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506730 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/506730
NON-HUMAN ANIMALS EXPRESSING HUMANIZED C1Q COMPLEX Oct 20, 2021 Abandoned
Array ( [id] => 18808614 [patent_doc_number] => 20230382948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => DELIVERY OF ENDOTHELIAL CELL-LADEN MICROGEL ELICITS ANGIOGENESIS IN SELF-ASSEMBLING ULTRASHORT PEPTIDE HYDROGELS [patent_app_type] => utility [patent_app_number] => 18/032351 [patent_app_country] => US [patent_app_date] => 2021-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17111 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032351 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/032351
DELIVERY OF ENDOTHELIAL CELL-LADEN MICROGEL ELICITS ANGIOGENESIS IN SELF-ASSEMBLING ULTRASHORT PEPTIDE HYDROGELS Oct 19, 2021 Pending
Array ( [id] => 20402412 [patent_doc_number] => 12492382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Blood type O Rh--hypo-immunogenic cells [patent_app_type] => utility [patent_app_number] => 17/504502 [patent_app_country] => US [patent_app_date] => 2021-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16459 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17504502 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/504502
Blood type O Rh--hypo-immunogenic cells Oct 18, 2021 Issued
Array ( [id] => 17657385 [patent_doc_number] => 20220177850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/503143 [patent_app_country] => US [patent_app_date] => 2021-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8159 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503143 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/503143
Methods for generating stem cell-derived b cells and methods of use thereof Oct 14, 2021 Issued
Array ( [id] => 17354546 [patent_doc_number] => 20220015342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => GENE EDITING OF REPRODUCTIVE HORMONES TO REDUCE FERTILITY IN ICTALURUS PUNCTATUS [patent_app_type] => utility [patent_app_number] => 17/498110 [patent_app_country] => US [patent_app_date] => 2021-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19127 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17498110 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/498110
GENE EDITING OF REPRODUCTIVE HORMONES TO REDUCE FERTILITY IN ICTALURUS PUNCTATUS Oct 10, 2021 Abandoned
Array ( [id] => 17385918 [patent_doc_number] => 20220033770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => MACS-BASED PURIFICATION OF STEM CELL-DERIVED RETINAL PIGMENT EPITHELIUM [patent_app_type] => utility [patent_app_number] => 17/493533 [patent_app_country] => US [patent_app_date] => 2021-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493533 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/493533
Macs-based purification of stem cell-derived retinal pigment epithelium Oct 3, 2021 Issued
Array ( [id] => 17457881 [patent_doc_number] => 20220071185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD137 [patent_app_type] => utility [patent_app_number] => 17/482991 [patent_app_country] => US [patent_app_date] => 2021-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22239 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482991 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/482991
GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD137 Sep 22, 2021 Abandoned
Array ( [id] => 19381218 [patent_doc_number] => 20240271088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => METHOD FOR MAINTAINING AND AMPLIFYING HUMAN PRIMORDIAL GERM CELLS / HUMAN PRIMORDIAL GERM CELL-LIKE CELLS [patent_app_type] => utility [patent_app_number] => 18/042134 [patent_app_country] => US [patent_app_date] => 2021-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042134 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/042134
METHOD FOR MAINTAINING AND AMPLIFYING HUMAN PRIMORDIAL GERM CELLS / HUMAN PRIMORDIAL GERM CELL-LIKE CELLS Aug 16, 2021 Pending
Array ( [id] => 17688099 [patent_doc_number] => 20220195391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => PLATELET-RICH PLASMA COMPOSITIONS AND METHODS OF PREPARATION [patent_app_type] => utility [patent_app_number] => 17/444009 [patent_app_country] => US [patent_app_date] => 2021-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11535 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17444009 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/444009
PLATELET-RICH PLASMA COMPOSITIONS AND METHODS OF PREPARATION Jul 28, 2021 Abandoned
Array ( [id] => 20881282 [patent_doc_number] => 12697301 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-08-04 [patent_title] => Pulmonary delivery of mRNA to non-lung target cells [patent_app_type] => utility [patent_app_number] => 17/389016 [patent_app_country] => US [patent_app_date] => 2021-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 23557 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389016 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/389016
Pulmonary Delivery of MRNA to Non-lung Target Cells Jul 28, 2021 Pending
Menu